Study of Dietary Risk Factors Associated with the Onset or Worsening of Complications in Chronic Viral Hepatitis B

Kponou Mathieu Bienvenu TOBOSSI^1, , Mamatchi MELILA², Lochina FETEKE³, Mlatovi DEGBE², Bawou Toussaint BANAKINAO² and Haziz SINA¹

¹Department of Biochemistry and Cell Biology, Faculty of Sciences and Technologies, University of Abomey - Calavi (Benin); 01 BP 526, Cotonou – Benin

²Department of Biochemistry, Faculty of Sciences, University of Lomé (Togo); 01 BP 1515 Lomé 01 - Togo

³Faculty of Health Sciences, University of Lomé (Togo); 01 BP 1515 Lomé 01 - Togo

Cite this paper:
Kponou Mathieu Bienvenu TOBOSSI, Mamatchi MELILA, Lochina FETEKE, Mlatovi DEGBE, Bawou Toussaint BANAKINAO and Haziz SINA. Study of Dietary Risk Factors Associated with the Onset or Worsening of Complications in Chronic Viral Hepatitis B. American Journal of Food and Nutrition. 2025; 13(5):158-163. doi: 10.12691/ajfn-13-5-1

Abstract

Background: Chronic hepatitis B (HBV) infection is a major public health issue in sub-Saharan Africa, frequently leading to severe clinical complications like cirrhosis and hepatocellular carcinoma. While diet is a known modulator of liver health, its specific role in the progression of HBV in the Togolese context is poorly documented. This study aimed to identify dietary risk factors associated with the onset or worsening of clinical complications in patients with chronic hepatitis B. Methods: A retrospective case-control study was conducted at a specialized hepatitis care facility in Lomé, Togo. We enrolled 212 HBsAg-positive adults, comprising 106 "cases" with at least one documented HBV-related clinical complication and 106 age- and sex-matched "controls" without such complications. Dietary habits preceding the onset of complications were assessed using a standardized questionnaire. Multivariate logistic regression was used to analyze the association between food consumption frequency and clinical outcomes, adjusting for potential confounders. Results: The frequent consumption of several food categories was significantly associated with an increased risk of clinical complications (p < 0.05). These included alcoholic beverages, high-lipid foods (fried items, certain sauces), high-carbohydrate foods (fermented pastes, refined sugar), red meat, and bouillon cubes. Conversely, a regular intake of leafy green vegetable-based sauces was found to be significantly associated with a lower risk of complications. Conclusion: Our findings suggest that a dietary pattern characterized by the high-frequency consumption of pro-inflammatory, high-energy foods is a significant risk factor for the progression of chronic hepatitis B in the Togolese setting. These results underscore the urgent need to integrate medical nutrition therapy and patient education into the standard of care to mitigate the risk of severe liver disease.

Keywords:
Hepatitis of viral origin B dietary determinants of risk clinical complicationsnutrition Togo

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	World Health Organization. Global hepatitis report 2024: action for access in low-and middle-income countries. Geneva: World Health Organization; 2024.
[2]	Stanaway JD, Flaxman AD, Naghavi M, Fitzmaurice C, Vos T, Abubakar I, et al. The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013. Lancet 2016; 388(10049): 1081-8.
[3]	Liaw YF, Chu CM. Hepatitis B virus infection. Lancet 2009; 373(9663): 582-92.
[4]	Mokaya J. Investigating drug and vaccine resistance as a challenge for hepatitis B virus elimination in Africa [dissertation]. Oxford: University of Oxford; 2020.
[5]	Mabaya S, Munongo E, Mapako T, Marowa L, Pasipanodya JG, Mutenherwa M. Prevalence and trends of Hepatitis B and C virus biomarkers in Zimbabwe: analyses of a nation's blood-donor surveillance data, 2015 through 2018, plus systematic review and meta-analyses of population studies. Am J Trop Med Hyg 2021; 105(6): 1706-18.
[6]	Asandem DA, Segbefia SP, Kusi KA, Bonney JHK. Hepatitis B virus infection: A mini review. Viruses 2024; 16(5): 724.
[7]	Jeng KS, Chang CF, Sheen IS, Jeng CJ, Wang CH. Upper gastrointestinal cancer and liver cirrhosis. Cancers 2022; 14(9): 2269.
[8]	Buzzetti E, Pinzani M, Tsochatzis EA. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism 2016; 65(8): 1038-48.
[9]	Management of patients with dual chronic hepatitis B and non-alcoholic fatty liver disease. J Hepatol 2021; 74: 951-61.
[10]	Arriola-Montenegro J, Beas R, Cerna-Viacava R, Chaponan-Lavalle A, Randich KH, Chambergo-Michilot D, et al. Therapies for patients with coexisting heart failure with reduced ejection fraction and non-alcoholic fatty liver disease. World J Cardiol 2023; 15(7): 328.
[11]	Oyiro PO, Roidad N, Monga M, Guilfoose J, Fisher MA, Remick SC. Transmissible Agents, HIV, and Cancer. In: Sullivan R, Jaffray D, Gospodarowicz M, editors. Global Perspectives on Cancer. Hoboken, NJ: John Wiley & Sons; 2015.
[12]	Yu MW, Lin CL, Liu CJ, Yang SH, Tseng YL, Wu CF. Influence of metabolic risk factors on risk of hepatocellular carcinoma and liver-related death in men with chronic hepatitis B: a large cohort study. Gastroenterology 2017; 153(4): 1006-17.
[13]	World Health Organization. Guidelines for the prevention care and treatment of persons with chronic hepatitis B infection: Mar-15. Geneva: World Health Organization; 2015.
[14]	McMahon BJ. The natural history of chronic hepatitis B virus infection. Hepatology 2009; 49(S5): S45-55.
[15]	Donato F, Tagger A, Gelatti U, Parrinello G, Boffetta P, Albertini A, et al. Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women. Am J Epidemiol 2002; 155(4): 323-31.
[16]	Seitz HK, Bataller R, Cortez-Pinto H, Gao B, Gual A, Lackner C, et al. Alcoholic liver disease. Nat Rev Dis Primers 2018; 4(1): 16.
[17]	Lin CW, Lin CC, Mo LR, Chang CY, Perng DS, Hsu CC, et al. Heavy alcohol consumption increases the incidence of hepatocellular carcinoma in hepatitis B virus-related cirrhosis. J Hepatol 2013; 58(4): 730-5.
[18]	Loomba R, Sanyal AJ. The global NAFLD epidemic. Nat Rev Gastroenterol Hepatol 2013; 10(11): 686-90.
[19]	Musio A, Perazza F, Leoni L, Stefanini B, Dajti E, Menozzi R, et al. Osteosarcopenia in NAFLD/MAFLD: an underappreciated clinical problem in chronic liver disease. Int J Mol Sci 2023; 24(8): 7517.
[20]	Wong VWS, Chan SL, Mo F, Chan TC, Loong HHF, Wong GLH, et al. Clinical scoring system to predict hepatocellular carcinoma in chronic hepatitis B carriers. J Clin Oncol 2010; 28(10): 1660-5.
[21]	Zelber-Sagi S, Ivancovsky-Wajcman D, Isakov NF, Webb M, Orenstein D, Shibolet O, et al. High red and processed meat consumption is associated with non-alcoholic fatty liver disease and insulin resistance. J Hepatol 2018; 68(6): 1239-46.
[22]	Chen L, Guo W, Mao C, Shen J, Wan M. Liver fibrosis: pathological features, clinical treatment and application of therapeutic nanoagents. J Mater Chem B 2024; 12(6): 1446-66.
[23]	Diniz YS, Faine LA, Galhardi CM, Rodrigues HG, Ebaid GX, Burneiko RC, et al. Monosodium glutamate in standard and high-fiber diets: metabolic syndrome and oxidative stress in rats. Nutrition 2005; 21: 749-55.
[24]	Farahani A, Farahani A, Kashfi K, Ghasemi A. Inhibition of hepatic gluconeogenesis in type 2 diabetes by metformin: complementary role of nitric oxide. Med Gas Res 2025; 15(4): 507-19.
[25]	Zhang CY, Liu S, Yang M. Treatment of liver fibrosis: Past, current, and future. World J Hepatol 2023; 15(6): 755.
[26]	Albillos A, De Gottardi A, Rescigno M. The gut-liver axis in liver disease: Pathophysiological basis for therapy. J Hepatol 2020; 72(3): 558-77.
[27]	Gadiraju TV, Patel Y, Gaziano JM, Djoussé L. Fried food consumption and cardiovascular health: a review of current evidence. Nutrients 2015; 7(10): 8424-30.
[28]	Subar AF, Dodd KW, Guenther PM, Kipnis V, Midthune D, McDowell M, et al. The food propensity questionnaire: concept, development, and validation for use as a covariate in a model to estimate usual food intake. J Am Diet Assoc 2006; 106(10): 1556-63.
[29]	Dusheiko G. Unmet Needs in Clinical Research Hepatitis B. In: Ma H, editor. Hepatitis B Virus and Liver Disease. Singapore: Springer; 2021. p. 51-71.
[30]	Isac T, Isac S, Ioanitescu S, Mihaly E, Tanasescu MD, Balan DG, et al. Dynamics of serum α-fetoprotein in viral hepatitis C without hepatocellular carcinoma. Exp Ther Med 2021; 22(1): 749.